The effect of ciprofloxacin on CD14 and toll-like receptor-4 expression on human monocytes

Shock

Volumn 25, Issue 3, 2006, Pages 247-253

  Katsuno, Goutaro ^a   Takahashi, Hideo Kohka ^a   Iwagaki, Hiromi ^a   Sugita, Sachi ^a   Mori, Shuji ^a   Saito, Shinnya ^a   Yoshino, Tadashi ^a   Nishibori, Masahiro ^a   Tanaka, Noriaki ^a  

^a OKAYAMA UNIVERSITY   (Japan)

Author keywords

CD14; Ciprofloxacin; Lipopolysaccharide; Monocyte; Prostaglandin; Toll like receptor 4

Indexed keywords

CD14 ANTIGEN; CD40 ANTIGEN; CIPROFLOXACIN; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLIC AMP DEPENDENT PROTEIN KINASE INHIBITOR; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITOR; HLA B7 ANTIGEN; HLA B7.1 ANTIGEN; HLA B7.2 ANTIGEN; INDOMETACIN; INTERCELLULAR ADHESION MOLECULE 1; LIPOPOLYSACCHARIDE; N (2 CYCLOHEXYLOXY 4 NITROPHENYL)METHANESULFONAMIDE; N [2 (4 BROMOCINNAMYLAMINO)ETHYL] 5 ISOQUINOLINESULFONAMIDE; PROSTAGLANDIN E2; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; LEUKOCYTE ANTIGEN;

ANTIGEN EXPRESSION; ARTICLE; CELL ACTIVATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG EFFECT; DRUG MECHANISM; HUMAN; HUMAN CELL; IMMUNE RESPONSE; INFLAMMATION; MACROPHAGE; MONOCYTE; NORMAL HUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PROSTAGLANDIN SYNTHESIS; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; BLOOD; IN VITRO STUDY; KINETICS; METABOLISM; PHYSIOLOGY;

ANTIGENS, CD; ANTIGENS, CD14; CIPROFLOXACIN; DINOPROSTONE; HUMANS; INDOMETHACIN; INTERCELLULAR ADHESION MOLECULE-1; KINETICS; LIPOPOLYSACCHARIDES; MONOCYTES; TOLL-LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR-ALPHA;

EID: 33646082023     PISSN: 10732322     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.shk.0000208803.50914.a2     Document Type: Article

References (29)

1. Mayeux PR: Pathobiology of lipopolysaccharide. J Toxicol Environ Health 51:415-435, 1997.
2. Cauwels A, Frei K, Sansano S, Fearns C, Ulevitch R, Zimmerli W, Landmann R: The origin and function of soluble CD14 in experimental bacterial meningitis. J Immunol 162:4762-4772, 1999.
3. Verbon A, Dekkers PE, ten Hove T, Hack CE, Pribble JP, Turner T, Souza S, Axtelle T, Hoek FJ, van Deventer SJ: IC14, an anti-CD14 antibody, inhibits endotoxin-mediated symptoms and inflammatory responses in humans. J Immunol 166:3599-3605, 2001.
4. Armstrong L, Medford AR, Hunter KJ, Uppington KM, Millar AB: Differential expression of Toll-like receptor (TLR)-2 and TLR-4 on monocytes in human sepsis. Clin Exp Immunol 136:312-319, 2004.
5. Tsujimoto H, Ono S, Majima T, Kawarabayashi N, Takayama E, Kinoshita M, Seki S, Hiraide H, Moldawer LL, Mochizuki H: Neutrophil elastase, MIP-2, and TLR-4 expression during human and experimental sepsis. Shock 23:39-44, 2005.
6. Tsujimoto H, Ono S, Hiraki S, Majima T, Kawarabayashi N, Sugasawa H, Kinoshita M, Hiraide H, Mochizuki H: Hemoperfusion with polymyxin B-immobilized fibers reduced the number of CD16+ CD14+ monocytes in patients with septic shock. J Endotoxin Res 10:229-237, 2004.
7. Mattern T, Thanhauser A, Reiling N, Toellner KM, Duchrow M, Kusumoto S, Rietschel ET, Ernst M, Brade H: Endotoxin and lipid A stimulate proliferation of human T cells in the presence of autologous monocytes. J Immunol 153:2996-3004, 1994.
8. Mattern T, Reich C, Duchrow M, Ansorge S, Ulmer AJ, Flad HD: Stimulation of human T lymphocytes by LPS is MHC unrestricted, but strongly dependent on B7 interactions. J Immunol 160:3412-3418, 1998.
9. Chirathaworn C, Kohlmeier JE, Tibbetts SA, Rumsey LM, Chan MA, Benedict SH: Stimulation through intercellular adhesion molecule-1 provides a second signal for T cell activation. J Immunol 168:5530-5537, 2002.
10. Lee SH, Soyoola E, Chanmugam P, Hart S, Sun W, Zhong H, Liou S, Simmons D, Hwang D: Selective expression of mitogen-inducible cyclooxygenase in macrophages stimulated with lipopolysaccharide. J Biol Chem 267:25934-25938, 1992.
11. Hempel SL, Monick MM, Hunninghake GW: Lipopolysaccharide induces prostaglandin H synthase-2 protein and mRNA in human alveolar macrophages and blood monocytes. J Clin Invest 93:391-396, 1994.
12. 2 acts at two distinct pathways of T lymphocyte activation: inhibition of interleukin production and down-regulation of transferrin receptor expression. J Immunol 135:1172-1179, 1985.
13. Taffet SM, Russell SW: Macrophage-mediated tumor cell killing: regulation of expression of cytolytic activity by prostaglandin E. J Immunol 126:424-427, 1981.
14. Vogel SN, Weedon LL, Oppenheim JJ, Rosenstreich DL: Defective Fc-mediated phagocytosis in C3H/HeJ macrophages: correction by cAMP agonists. J Immunol 126:441-445, 1981.
15. Coleman RA, Smith WL, Narumiya S: VIII-international Union of Pharmacology classification of prostanoid receptors: properties, distribution and structure of the receptors and their subtypes. Pharmacol Rev 46:205-229, 1994.
16. 2 receptor EP2 subtype. J Biol Chem 269:11873-11877, 1994.
17. 2 on intercellular adhesion molecule-1 and B7 expression in mixed lymphocyte reaction. Transplantation 75:2100-2105, 2003.
18. 2 on lipopolysaccharide-induced adhesion molecule expression on human monocytes. Eur J Pharmacol 512:223-230, 2005.
19. Morichika T, Takahashi HK, Iwagaki H, Yoshino T, Tamura R, Yokoyama S, Mon S, Akagi T, Nishibori M, Tanaka N: Histamine inhibits lipopolysaccharide- induced tumor necrosis factor-alpha production in an intercellular adhesion molecule-1-and B7.1-dependent manner. J Pharmacol Exp Ther 304:624-633, 2003.
20. Khan AA, Slifer TR, Araujo FG, Suzuki Y, Remington JS: Protection against lipopolysaccharide-induced death by fluoroquinolones. Antimicrob Agents Chemother 44:3169-3173, 2000.
21. Beelen DW, Elmaagacli A, Muller KD, Hirche H, Schaefer UW: Influence of intestinal bacterial decontamination using metronidazole and ciprofloxacin or ciprofloxacin alone on the development of acute graft-versus-host disease after marrow transplantation in patients with hematologic malignancies: final results and long-term follow-up of an open-label prospective randomized trial. Blood 93:3267-3275, 1999.
22. Riesbeck K, Sigvardsson M, Leanderson T, Forsgren A: Superinduction of cytokine gene transcription by ciprofloxacin. J Immunol 153:343-352, 1994.
23. Trautmann M, Heinemann M, Moricke A, Seidelmann M, Lorenz I, Berger D, Steinbach G, Schneider M: Endotoxin release due to ciprofloxacin measured by three different methods. J Chemother 11:248-254, 1999.
24. Stunkel KG, Hewlett G, Zeiler HJ: Ciprofloxacin enhances T cell function by modulating interleukin activities. Clin Exp Immunol 86:525-531, 1991.
25. Dalhoff A, Shalit I: Immunomodulatory effects of quinolones. Lancet Infect Dis 3:359-371, 2003.
26. Takahashi HK, Iwagaki H, Katsuno G, Sugita S, Mizuno K, Mori S, Saito S, Yoshino T, Tanaka N, Nishibori M: Effect of Ciprofloxacin-induced PGE2 on IL-18-treated monocytes. Antimicrob Agents Chemother 49:3228-3233, 2005.
27. Takahashi HK, Iwagaki H, Tamura R, Xue D, Sano M, Mori S, Yoshino T, Tanaka N, Nishibori M: Unique regulation profile of prostaglandin E1 on adhesion molecule expression and cytokine production in human peripheral blood mononuclear cells. J Pharmacol Exp Ther 307:1188-1195, 2003.
28. Yaqub S, Solhaug V, Vang T, Solberg R, Aasen A, Tasken K, Wang JE: A human whole blood model of LPS-mediated suppression of T cell activation. Med Sci Monit 9:BR120-BR126, 2003.
29. Dooper MM, Wassink L, M'Rabet L, Graus YM: The modulatory effects of prostaglandin-E on cytokine production by human peripheral blood mononuclear cells are independent of the prostaglandin subtype. Immunology 107:152-159, 2002.